| Treatment Approach | Non-invasive laser therapy | Prescription oral retinoid | Medicated creams, gels, or cleansers |
|---|
| Primary Action | May reduce inflammatory lesions and improve acne-related redness | Reduces sebum production and addresses multiple acne pathways | Targets clogged pores, bacteria, and inflammation depending on formulation |
|---|
| Best Suited For | Selected inflammatory acne concerns and patients seeking an adjunctive treatment | Severe, scarring, or treatment-resistant acne | Mild to moderate acne and ongoing maintenance |
|---|
| Treatment Experience | In-clinic sessions with generally mild warmth | Daily oral medication under medical supervision | Regular at-home application |
|---|
| Potential Side Effects | Temporary redness, swelling, pigment changes, or other laser-related reactions | Dryness and other possible systemic adverse effects requiring monitoring | Dryness, irritation, or peeling depending on the product |
|---|
| Treatment Duration | Usually a series of sessions | Typically a prescribed course over several months | Ongoing use, with results developing over weeks |
|---|
| Skin Tone Considerations | Can be suitable for Fitzpatrick I–VI with appropriate settings | Suitable across skin tones with medical assessment | Many formulations are suitable across skin tones; irritation management is important |
|---|
| Clinical Role | Adjunctive or selected-case treatment; evidence is less established than for standard acne medications | Established treatment for appropriately selected severe acne | Common first-line treatment for many acne presentations |
|---|